Sinemet CR For Parkinson's Disease
Controlled-release carbidopa/levodopa (Sinemet CR - Dupont Pharma) was recently approved by the US Food and Drug Administration for treatment of Parkinson's disease. The new formulation of this old combination (Sinemet) has the drugs suspended in a polymeric matrix that erodes slowly in the gastrointestinal tract....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Sinemet CR For Parkinson's Disease
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 854
Article Code: 854b
Date: October 4, 1991
Volume: 33
Pages: 92-93
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 854
Article Code: 854b
Date: October 4, 1991
Volume: 33
Pages: 92-93
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)